Acino Holding AG (LTS:0QM8) Days Payable: 0.00 (As of Dec. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acino Holding AG Days Payable?

Acino Holding AG LTS:0QM8 Days Payable is 0.00 as of Dec. 2013.

Acino Holding AG's average Accounts Payable for the six months ended in Dec. 2013 was CHF0.00 Mil. Acino Holding AG's Cost of Goods Sold for the six months ended in Dec. 2013 was CHF106.02 Mil. Hence, Acino Holding AG's Days Payable for the six months ended in Dec. 2013 was 0.00.

The historical rank and industry rank for Acino Holding AG's Days Payable or its related term are showing as below:

LTS:0QM8's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.38
* Ranked among companies with meaningful Days Payable only.

Acino Holding AG's Days Payable declined from Dec. 2011 (96.81) to Dec. 2013 (0.00). It may suggest that Acino Holding AG accelerated paying its suppliers.

Acino Holding AG Days Payable Historical Data

* Premium members only.

The historical data trend for Acino Holding AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acino Holding AG Days Payable Chart

Acino Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.80 70.02 96.81 61.05 0.00

Acino Holding AG Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 82.80 70.02 96.81 61.05 0.00

Acino Holding AG Days Payable Competitor Comparison

For the Drug Manufacturers - General subindustry, Acino Holding AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acino Holding AG Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acino Holding AG's Days Payable distribution charts can be found below:

* The bar in red indicates where Acino Holding AG's Days Payable falls into.


Acino Holding AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Acino Holding AG's Days Payable for the fiscal year that ended in Dec. 2013 is calculated as

Days Payable (A: Dec. 2013 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2012 ) + Accounts Payable (A: Dec. 2013 )) / count ) / Cost of Goods Sold (A: Dec. 2013 )*Days in Period
=( (0 + 0) / 1 ) / 106.021*365
=0 / 106.021*365
=0.00

Acino Holding AG's Days Payable for the quarter that ended in Dec. 2013 is calculated as:

Days Payable (Q: Dec. 2013 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2012 ) + Accounts Payable (Q: Dec. 2013 )) / count ) / Cost of Goods Sold (Q: Dec. 2013 )*Days in Period
=( (0 + 0) / 1 ) / 106.021*365 / 2
=0 / 106.021*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Acino Holding AG (LTS:0QM8) has a Days Payable of 0.00 as of Dec. 2013. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Acino Holding AG and its competitors.
Is Acino Holding AG's Days Payable too high?
Acino Holding AG's current Days Payable is 0.00.
How does Acino Holding AG's Days Payable compare to competitors?
Acino Holding AG's Days Payable of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Acino Holding AG and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acino Holding AG's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acino Holding AG stock overvalued right now?
Acino Holding AG (LTS:0QM8) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Acino Holding AG (LTS:0QM8), the current Days Payable is 0.00 as of Dec. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acino Holding AG Business Description

Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.